翻訳と辞書 |
BioCryst Pharmaceuticals : ウィキペディア英語版 | BioCryst Pharmaceuticals
BioCryst Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Durham, North Carolina. The company focuses on orphan & autoimmune diseases, and antivirals.〔 The company's most advanced drug candidate is the antiviral Peramivir, which is approved in Japan, Korea and China. It was authorized by the FDA for emergency use in the treatment of patients hospitalized with influenza during the 2009-10 influenza A virus subtype H1N1〔 〕 pandemic. ==History== The company was founded in 1986 by Charles E. Bugg, Ph.D. and John A. Montgomery, Ph.D. In March 1994, BioCryst became a public company when it completed an Initial Public Offering by listing its shares on the NASDAQ stock exchange. In 2008 the company was named one of the fastest growing companies by Deloitte & Touche in its 2008 list of ''Technology Fast 500''.〔''(BioCryst named 29th fastest growing tech firm ) Birmingham Business Journal'', November 26, 2008〕 In October 2010, BioCryst announced its headquarters would move to Durham, North Carolina, where the company has had an office since 2006.
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「BioCryst Pharmaceuticals」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|